![Edward Albini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Albini
Keine laufenden Positionen mehr
Vermögen: 533 889 $ am 30.06.2026
Profil
Edward C.
Albini formerly worked at Genentech, Inc., as Director-Finance & International Operations, Lynx Therapeutics, Inc., as Chief Financial Officer from 1997 to 2004, Carbylan Therapeutics, Inc., as Chief Financial Officer, Itero Biopharmaceuticals, Inc., as Chief Financial Officer & Senior Vice President from 2009 to 2011, Sutro Biopharma, Inc., as Chief Financial Officer & Secretary from 2013 to 2025, Novacea, Inc., as Chief Financial Officer from 2004 to 2009, and Itero Holdings LLC, as Chief Financial Officer & Secretary from 2011 to 2016.
Mr. Albini received his undergraduate degree from Santa Clara University and Masters Business Admin degree from Haas School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.05.2025 | 16’081 ( 0.1% ) | 533 889 $ | 30.06.2026 |
Ehemalige bekannte Positionen von Edward Albini
| Unternehmen | Position | Ende |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Finanzdirektor/CFO | 15.05.2025 |
Itero Holdings LLC
 Itero Holdings LLC Financial ConglomeratesFinance Provides investment services | Finanzdirektor/CFO | 01.01.2016 |
Itero Biopharmaceuticals, Inc.
 Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Finanzdirektor/CFO | 01.01.2011 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Finanzdirektor/CFO | 01.01.2009 |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Finanzdirektor/CFO | 01.02.2004 |
Ausbildung von Edward Albini
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Itero Holdings LLC
Itero Holdings LLC Financial ConglomeratesFinance Provides investment services | Finance |
